Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$56.16 - $60.96 $1.6 Million - $1.74 Million
-28,552 Reduced 83.97%
5,450 $330,000
Q2 2024

Jul 18, 2024

SELL
$53.58 - $57.02 $42.9 Million - $45.7 Million
-801,027 Reduced 95.93%
34,002 $1.91 Million
Q1 2024

Apr 24, 2024

BUY
$42.56 - $59.82 $16.8 Million - $23.7 Million
395,629 Added 90.04%
835,029 $47.1 Million
Q4 2023

Jan 17, 2024

SELL
$32.18 - $46.57 $46.2 Million - $66.9 Million
-1,436,429 Reduced 76.58%
439,400 $19.7 Million
Q3 2023

Nov 06, 2023

BUY
$44.2 - $50.2 $18.9 Million - $21.5 Million
428,260 Added 29.58%
1,875,829 $85.4 Million
Q2 2023

Jul 25, 2023

BUY
$31.86 - $67.26 $46.1 Million - $97.4 Million
1,447,569 New
1,447,569 $62.8 Million
Q4 2022

Jan 12, 2023

SELL
$41.39 - $81.0 $1.37 Million - $2.69 Million
-33,210 Reduced 85.92%
5,443 $245,000
Q3 2022

Oct 27, 2022

BUY
$72.36 - $113.1 $1.12 Million - $1.76 Million
15,544 Added 67.26%
38,653 $2.8 Million
Q2 2022

Jul 27, 2022

BUY
$87.2 - $114.05 $762,389 - $997,139
8,743 Added 60.86%
23,109 $2.48 Million
Q1 2022

Apr 25, 2022

BUY
$94.19 - $124.49 $50,956 - $67,349
541 Added 3.91%
14,366 $1.59 Million
Q4 2021

Feb 01, 2022

SELL
$119.57 - $139.07 $25.3 Million - $29.4 Million
-211,716 Reduced 93.87%
13,825 $1.77 Million
Q3 2021

Oct 19, 2021

BUY
$109.17 - $142.35 $10.8 Million - $14.1 Million
99,292 Added 78.65%
225,541 $30 Million
Q2 2021

Jul 15, 2021

BUY
$100.34 - $115.69 $11.9 Million - $13.7 Million
118,224 Added 1473.2%
126,249 $13.7 Million
Q1 2021

Apr 26, 2021

SELL
$101.51 - $125.27 $27.3 Million - $33.6 Million
-268,529 Reduced 97.1%
8,025 $845,000
Q4 2020

Feb 01, 2021

BUY
$85.88 - $105.36 $23.2 Million - $28.4 Million
269,718 Added 3945.55%
276,554 $28.8 Million
Q3 2020

Oct 07, 2020

BUY
$72.74 - $92.5 $497,250 - $632,330
6,836 New
6,836 $586,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.